(Q45353745)

13 December 2017

title

Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases (English)

1 reference

13 December 2017

0 references

8

1 reference

13 December 2017

Armando Santoro

6

1 reference

ORCID Public Data File 2021

author name string

Elena Miranda

1

1 reference

13 December 2017

Paolo Bianchi

2

1 reference

13 December 2017

Annarita Destro

3

1 reference

13 December 2017

Emanuela Morenghi

4

1 reference

13 December 2017

Alberto Malesci

5

1 reference

13 December 2017

Luigi Laghi

7

1 reference

13 December 2017

language of work or name

English

0 references

publication date

11 July 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

119

1 reference

13 December 2017

issue

2

1 reference

13 December 2017

page(s)

266-276

1 reference

Molecular biology of colorectal cancer

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Mouse models of colorectal cancer and liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Systemic therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Genetic and molecular diversity of colon cancer hepatic metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Tracing the origins of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Cancer as an evolutionary and ecological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

inferred from DOI database lookup

7 January 2021

based on heuristic

High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

inferred from DOI database lookup

7 January 2021

based on heuristic

Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27722

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.27722

1 reference

13 December 2017

1 reference